← Back to directory

Pia Raanani

Researcher Next ID · RN-042098

Researcher · Medicine

Tel Aviv University

Tel Aviv, Israel

Accepting doctoral researchersFunding unknown
Works count
567
Citation count
6,399
H-index
42
i10-index
148

Research interests

Medicine
Chronic Lymphocytic Leukemia Research
Acute Myeloid Leukemia Research
Chronic Myeloid Leukemia Treatments
Lymphoma Diagnosis and Treatment
Acute Lymphoblastic Leukemia research

Publications

  • An improved index for diagnosis and mortality prediction in malignancy-associated hemophagocytic lymphohistiocytosis

    Blood · 2021 · 10.1182/blood.2021012764

  • Venous thromboembolism incidence and risk assessment in lung cancer patients treated with immune checkpoint inhibitors

    Journal of Thrombosis and Haemostasis · 2021 · 10.1111/jth.15272

  • Primary analysis of JUMP, a phase 3b, expanded‐access study evaluating the safety and efficacy of ruxolitinib in patients with myelofibrosis, including those with low platelet counts

    British Journal of Haematology · 2020 · 10.1111/bjh.16462

  • Venetoclax in patients with acute myeloid leukemia refractory to hypomethylating agents—a multicenter historical prospective study

    Annals of Hematology · 2019 · 10.1007/s00277-019-03719-6

  • Autologous Hematopoietic Stem Cell Transplantation for Systemic Sclerosis: A Systematic Review and Meta-Analysis

    Transplantation and Cellular Therapy · 2018 · 10.1016/j.bbmt.2018.01.020

  • Safety and efficacy of ruxolitinib in an open-label, multicenter, single-arm phase 3b expanded-access study in patients with myelofibrosis: a snapshot of 1144 patients in the JUMP trial

    Haematologica · 2016 · 10.3324/haematol.2016.143677

  • Ponatinib reduces viability, migration, and functionality of human endothelial cells

    Leukemia & lymphoma/Leukemia and lymphoma · 2016 · 10.1080/10428194.2016.1239258

  • Harnessing RNAi-based nanomedicines for therapeutic gene silencing in B-cell malignancies

    Proceedings of the National Academy of Sciences · 2015 · 10.1073/pnas.1519273113

  • Cell-specific uptake of mantle cell lymphoma-derived exosomes by malignant and non-malignant B-lymphocytes

    Cancer Letters · 2015 · 10.1016/j.canlet.2015.04.026

  • Cannabidiol for the Prevention of Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation: Results of a Phase II Study

    Transplantation and Cellular Therapy · 2015 · 10.1016/j.bbmt.2015.05.018

  • MiR-30e induces apoptosis and sensitizes K562 cells to imatinib treatment via regulation of the BCR–ABL protein

    Cancer Letters · 2014 · 10.1016/j.canlet.2014.10.006

  • Adolescents and young adults with acute lymphoblastic leukemia have a better outcome when treated with pediatric‐inspired regimens: Systematic review and meta‐analysis

    American Journal of Hematology · 2012 · 10.1002/ajh.23149

  • Management of adult patients with acute lymphoblastic leukemia in first complete remission

    Cancer · 2010 · 10.1002/cncr.25136

  • Immunoglobulin prophylaxis in chronic lymphocytic leukemia and multiple myeloma: systematic review and meta-analysis

    Leukemia & lymphoma/Leukemia and lymphoma · 2009 · 10.1080/10428190902856824

  • The late adverse events of rituximab therapy – rare but there!

    Leukemia & lymphoma/Leukemia and lymphoma · 2009 · 10.1080/10428190902934944

  • Lymphoma and Leukemia Cells Possess Fractal Dimensions That Correlate with Their Biological Features

    Acta Haematologica · 2008 · 10.1159/000125551

  • Immunoglobulin Prophylaxis in Hematopoietic Stem Cell Transplantation: Systematic Review and Meta-Analysis

    Journal of Clinical Oncology · 2008 · 10.1200/jco.2008.16.8450

  • Prophylaxis regimens for GVHD: systematic review and meta-analysis

    Bone Marrow Transplantation · 2008 · 10.1038/bmt.2008.373

  • Immunoglobulin prophylaxis in hematological malignancies and hematopoietic stem cell transplantation

    Cochrane Database of Systematic Reviews · 2008 · 10.1002/14651858.cd006501.pub2

  • Is CT scan still necessary for staging in Hodgkin and non-Hodgkin lymphoma patients in the PET/CT era?

    Annals of Oncology · 2005 · 10.1093/annonc/mdj024

  • Philadelphia-Chromosome-Positive T-Lymphoblastic Leukemia: Acute Leukemia or Chronic Myelogenous Leukemia Blastic Crisis

    Acta Haematologica · 2005 · 10.1159/000084448

  • Rituximab reduces relapse risk after allogeneic and autologous stem cell transplantation in patients with high‐risk aggressive non‐Hodgkin's lymphoma

    British Journal of Haematology · 2003 · 10.1046/j.1365-2141.2003.04446.x

  • Immune-Mediated Complications during Interferon Therapy in Hematological Patients

    Acta Haematologica · 2002 · 10.1159/000057631

  • The rate and kinetics of molecular response to donor leucocyte transfusions in chronic myeloid leukaemia patients treated for relapse after allogeneic bone marrow transplantation

    British Journal of Haematology · 1997 · 10.1046/j.1365-2141.1997.4683272.x

  • Intermittent Administration of Furosemide vs Continuous Infusion Preceded by a Loading Dose for Congestive Heart Failure

    CHEST Journal · 1992 · 10.1378/chest.102.3.725

Current projects

    No projects listed.